Abstract

BackgroundNepal’s poultry industry has increased with a growing middle class, which has translated to an increase in antimicrobial consumption and thus a rise in antimicrobial resistance (AMR). Describing and understanding antimicrobial use practices among commercial poultry producers in Nepal may help minimize the risks of AMR development in both humans and animals and determine the effectiveness of relevant policies.MethodsFrom July to August 2018, poultry farmers were randomly recruited from Nepal’s Chitwan District to participate in a cross-sectional study. The lead producer in each poultry operation was administered a quantitative structured-survey via a 30-min interview. Participants were asked to provide demographics, production practices, and knowledge about their antimicrobial use practices. Descriptive data analysis was performed to obtain frequencies and compare practices.ResultsIn total, 150 commercial poultry producers of whom raised between 300 and 40,000 birds completed the interviews. Only 33% (n = 49) of producers reported knowing what AMR was, and among them only 50% (n = 25) consulted a veterinarian for treatment options. Antimicrobial administration for growth promotion was still employed by 13% of poultry producers. Similarly, critically important antimicrobial drugs, specifically colistin, were identified at 35% of participating operations. Producers reported low overall understanding and compliance of withdrawal periods (n = 41; 27%), which may result in both AMR development and adverse health reactions among consumers who ingest antimicrobial residues. Although Nepal has publicized antimicrobial use policies and awareness campaigns to instill healthy production practices, most producers (82%) were unaware of them.ConclusionMany Nepalese poultry producers lack overall antimicrobial use and AMR awareness, which is evidenced by low antimicrobial withdrawal period compliance, use of antimicrobials for growth promotion, and the sustained use of critically important antimicrobials. Improved outreach and educational capacities, paired with increased veterinary resources and extensive monitoring in operations and retail meat products, may increase AMR awareness and policy enforcement.

Highlights

  • Described as one of the most significant public health crises of our time, antimicrobial resistant organisms contribute to over 700,000 global deaths annually, a number estimated to reach 10 million by 2050 [1, 2]

  • It is estimated that animal agriculture purchases up to 73–100% more antimicrobials than human medicine, which is aligned with a rising middle class that demands animal-based protein [6,7,8]

  • Study design A cross-sectional survey of commercial poultry producers was performed in Chitwan District, Nepal between July and August 2018

Read more

Summary

Introduction

Described as one of the most significant public health crises of our time, antimicrobial resistant organisms contribute to over 700,000 global deaths annually, a number estimated to reach 10 million by 2050 [1, 2]. It is estimated that animal agriculture purchases up to 73–100% more antimicrobials than human medicine, which is aligned with a rising middle class that demands animal-based protein [6,7,8]. The Federal Democratic Republic of Nepal ( Nepal) fits this dual growth and has intensified the animal agriculture sector—notably in the Chitwan district. This district produces 40% of the nation’s egg supply and is dovetailed with increases in antimicrobial drug procurement, which has increased by 50% between 2008 and 2012 [9, 10]. Nepal’s poultry industry has increased with a growing middle class, which has translated to an increase in antimicrobial consumption and a rise in antimicrobial resistance (AMR). Describing and understanding antimicrobial use practices among commercial poultry producers in Nepal may help minimize the risks of AMR development in both humans and animals and determine the effectiveness of relevant policies

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call